[Controlled clinical study on the activity of a new mucoregulating drug in obstructive bronchial pathology with a marked hypersecretory feature. The pediatric experience].
D000111:Acetylcysteine / Q000627:therapeutic use; D000293:Adolescent; D000551:Ambroxol / Q000627:therapeutic use*; D001964:Bromhexine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D001982:Bronchial Diseases / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D003550:Cystic Fibrosis / Q000150:complications; D005260:Female; D006801:Humans; D008297:Male; D009093:Mucus / Q000378:metabolism
D000551:Ambroxol; D001964:Bromhexine; D000111:Acetylcysteine
Studio clinico controllato sull'attività di un nuovo farmaco mucoregolatore nella patologia ostruttiva bronchiale a marcata impronta ipersecretiva. Esperienza pediatrica.